Where does Cardiac Dimensions Pty. Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cardiac Dimensions Pty. Ltd. ranks #9,991 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cardiac Dimensions Pty. Ltd. hold?

Cardiac Dimensions Pty. Ltd. holds 31 US utility patents granted between 2015 and 2025, spanning 6 technology areas.

What is Cardiac Dimensions Pty. Ltd.'s Innovation Score?

Cardiac Dimensions Pty. Ltd. has an Innovation Score of 31.8 out of 100 (39th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cardiac Dimensions Pty. Ltd.'s patent grant rate increasing or decreasing?

Cardiac Dimensions Pty. Ltd.'s recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Cardiac Dimensions Pty. Ltd.'s patents?

Cardiac Dimensions Pty. Ltd.'s patents average 9.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cardiac Dimensions Pty. Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cardiac Dimensions Pty. Ltd.

Q: What technology areas does Cardiac Dimensions Pty. Ltd. focus on?

Cardiac Dimensions Pty. Ltd.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 29 patents, ranking #223 of 3,082 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 31 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cardiac ranks #9,991 of 49,997 tracked US assignees by granted-patent volume, with 31 patents across 6 technology areas.

#9,991
of 49,997 US assignees by volume: 39th percentile
by Innovation Score (31.8/100): 9.8
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9991 · US Corporation #9,991 · 31 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 31 grants
UPPER-Q #9,991/49,997
PHOTO-FINISH Calysta
CPC-NARROW A61F · 6 areas
INNOV-THIN 31.8/100
CLAIMS-PAR 9.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Calysta, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cardiac’s 31.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.0 pts (38%) Velocity 5.3 pts (17%) Breadth 8.7 pts (27%) Claim depth 5.9 pts (18%)

Qualcomm Incorporated · highest

85
Airbus DS SAS · near

32
Cardiac Dimensions Pty · this assignee

32
Deuteria Beverages · near

32
GI Therapeutics · near

32
Huntercraft · near

32
3D Lighting… · lowest

7

What this shows Cardiac's Innovation Score is 31.8/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cardiac?

Each dot is one of Cardiac’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cardiac’s own 9.8 claims/patent is at or below the 18.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Cardiac vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cardiac's grants concentrate

Cardiac Dimensions Pty. Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 93.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (8 grants) versus a trough of 1 in 2015. By volume, Cardiac sits between Comet Technologies USA, Inc. and Chrysler Group LLC.

Cardiac's three-year grant acceleration

Cardiac Dimensions Pty. Ltd. shows 8 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Comet USA

31
Control Techniques

31
Curt Manufacturing

31
Calysta

31
Cardioxyl Pharmac…

31
Celestial AI

31
Channel Medsystems

31
Chrysler Group

31
Cardiac Dimension… ◀

31

What this shows Cardiac holds 31 patents at rank #10,003, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cardiac

By rank, the assignees closest to #10,003 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Cardiac's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cardiac, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Cardiac ranks #223 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (32 here).

Airbus DS SAS 32 Deuteria Beverages, LLC 32 GI Therapeutics, Inc. 32 Huntercraft Limited 32

Cardiac's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Cardiac Dimensions Pty. Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.2%
2016	4	12.9%
2017	4	12.9%
2018	3	9.7%
2019	8	25.8%
2021	2	6.5%
2022	6	19.4%
2023	1	3.2%
2024	1	3.2%
2025partial year	1	3.2%

Which technologies does Cardiac Dimensions Pty. Ltd. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 29

A61B - DIAGNOSIS; SURGERY; Identification 18

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 13

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 2

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 2

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cardiac Dimensions Pty. Ltd.'s patent record in context - here's where to go next.

Cardiac Dimensions Pty. Ltd.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 93.5% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #9,991 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cardiac Dimensions Pty. Ltd. against Comet Technologies USA, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.